ProMACE-CytaBOM Regimen

Known as: Prednisone-Methotrexate-Adriamycin-Cytoxan-Etoposide-Cytarabine-Bleomycin-Oncovin-Methotrexate Regimen 
A non-cross resistant regimen consisting of prednisone, methotrexate, doxorubicin, cyclophosphamide and etoposide (ProMACE) alternating with… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2010
0119962010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
We conducted a retrospective analysis on 168 adult patients with newly diagnosed, limited-stage (I and II) diffuse large B-cell… (More)
  • table I
  • figure 1
  • figure 2
  • table II
  • table III
Is this relevant?
2006
2006
BACKGROUND It is still unclear the actual contribute of dose intensity (DI), dose size (DS) and dose density (DD) in the… (More)
Is this relevant?
2005
2005
BACKGROUND & OBJECTIVE CHOP regimen is the routine modality for moderately or highly malignant non-Hodgkin's lymphoma (NHL… (More)
Is this relevant?
1997
1997
BACKGROUND The role of intensive conventional dose chemotherapy in advanced low grade non-Hodgkin's lymphomas is a matter of… (More)
Is this relevant?
1996
1996
PURPOSE The aim of this study was to determine the maximum-tolerated dose (MTD) of cyclophosphamide, doxorubicin, etoposide… (More)
Is this relevant?